Evidence map›Paper›PMID 32545450›Full record

ArticlePlants (Basel, Switzerland)2020

Development of

Chen Chen, Zijian Xiao, Junwen Zhang, Wei Li, Jinlong Li, Chenxu Liu, Shaojiang Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chen ChenNational Maize Improvement Center of China, College of Agronomy and Biotechnology, China Agricultural University, Yuanmingyuan West Road, Haidian District, 100193 Beijing, China.
Zijian XiaoNational Maize Improvement Center of China, College of Agronomy and Biotechnology, China Agricultural University, Yuanmingyuan West Road, Haidian District, 100193 Beijing, China.
Junwen ZhangNational Maize Improvement Center of China, College of Agronomy and Biotechnology, China Agricultural University, Yuanmingyuan West Road, Haidian District, 100193 Beijing, China.
Wei LiNational Maize Improvement Center of China, College of Agronomy and Biotechnology, China Agricultural University, Yuanmingyuan West Road, Haidian District, 100193 Beijing, China.
Jinlong LiNational Maize Improvement Center of China, College of Agronomy and Biotechnology, China Agricultural University, Yuanmingyuan West Road, Haidian District, 100193 Beijing, China.
Chenxu LiuNational Maize Improvement Center of China, College of Agronomy and Biotechnology, China Agricultural University, Yuanmingyuan West Road, Haidian District, 100193 Beijing, China.
Shaojiang ChenNational Maize Improvement Center of China, College of Agronomy and Biotechnology, China Agricultural University, Yuanmingyuan West Road, Haidian District, 100193 Beijing, China.
China Agricultural University · CN

Funding

Modern Maize Industry Technology System CARS-02-04National Key Research and Development Program of China 2016YFD0101201
6 · The paper itself

Abstract

Doubled haploid technology is widely applied in maize. The haploid inducer lines play critical roles in doubled haploid breeding. We report the development of specialized haploid inducer lines that enhance the purple pigmentation of crossing immature embryos. During the development of haploid inducer lines, two breeding populations derived from the CAU3/S23 and CAU5/S23 were used. Molecular marker-assisted selection for both

Indexed as

haploid identificationhaploid immature embryohaploid induction ratemaize

Identifiers

PMID32545450
PMCPMC7356152
OpenAlexW3035601281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.